Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:589-595, doi:10.1016/S0735-1097(02)02863-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sicari, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sicari, R.

Stress echo results predict mortality: a large-scale multicenter prospective international study

Rosa Sicari, MD, PhD*,*, Emilio Pasanisi, MD*, Lucia Venneri, MD*, Patrizia Landi, BSc*, Lauro Cortigiani, MD*, Eugenio Picano, MD, PhD* Echo Persantine International Cooperative (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups

* National Council of Research, Institute of Clinical Physiology, Pisa, Italy



View larger version (17K):

[in a new window]
 
Figure 1 Kaplan-Meier survival curves (considering cardiac death as an end point) in patients with presence (DET +) and absence (DET –) of myocardial ischemia at pharmacologic stress echocardiography. Survival is worse in patients with inducible ischemia.

 


View larger version (15K):

[in a new window]
 
Figure 2 Kaplan-Meier survival curves (considering total mortality as an end point) in patients with presence (DET +) and absence (DET –) of myocardial ischemia pharmacologic stress echocardiography. Survival is worse in patients with inducible ischemia.

 


View larger version (14K):

[in a new window]
 
Figure 3 Kaplan-Meier survival curves (considering death as an end point) in patients with a positive pharmacologic stress echo test separated on the basis of the extent of the inducible ischemia identified by the delta wall motion score index (WMSI) set at 0.37. The survival is worse for larger variations of WMSI; Delta WMSI >0.37 versus Delta WMSI <0.37.

 


View larger version (18K):

[in a new window]
 
Figure 4 Kaplan-Meier survival curves (considering cardiac death) in patients stratified according to DET test results in relation to the pharmacologic dose achieved. Low-dose positivity was considered to have occurred during the dose of 0.56 mg/kg in 4 min of dipyridamole or during the following 4 min or at the dose ≤20 µg/kg/min of dobutamine (high-dose positivity vs. low-dose positivity, p = 0.0000).

 


View larger version (13K):

[in a new window]
 
Figure 5 Bar graph showing global chi-square value of significant predictor modeling of cardiac mortality according to an interactive procedure. In the model, stress echocardiographic parameters still added significant information to clinical variables and rest echocardiographic parameters. WMSI = wall motion score index.

 


View larger version (15K):

[in a new window]
 
Figure 6 Bar graph showing global chi-square value of significant predictor modeling of total mortality according to an interactive procedure. In the model, stress echocardiographic parameters still added significant information to clinical variables and rest echocardiographic parameters. WMSI = wall motion score index.

 


View larger version (15K):

[in a new window]
 
Figure 7 Bar graph showing incremental value of pharmacologic stress echocardiography results to clinical characteristics and coronary angiography for prediction of cardiac outcome in 4,037 patients who underwent pharmacologic stress echocardiography and coronary angiography. WMSI = wall motion score index.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement